Rapid Bioavailability Test

The Promonitor family of tests measures both drug levels and anti-drug antibody levels with validated ELISA assays to complement biological therapies for drug monitoring. Testing for drug bioavailability and immunogenicity: IFX, Anti-IFX, ADL, Anti-ADL, RTX, Anti-RTX, ETN, Anti-ETN, GLM, Anti-GLM, VDZ, Anti-VDZ, UTK, Anti-UTK.

Optimize Therapy

Refine treatment of chronic inflammatory diseases with a personalized approach to therapy with biologics.

Individualized treatment for every patient, enabling a personalized approach to therapy with biologics

Early information about reduced drug efficacy - Promonitor provides an early warning if the treatment regime may require modification

Cost Effective

Reduce the use of ineffective treatment strategies, allowing a more efficient use of available resources.

Effectively manage resources with the information provided by Promonitor

Easy to Use
Quickly generate results with ELISA-based tests and readily available equipment.

Quick procedure - 4 simple steps

Microplate precoated and ready-to-use reagents

Easy data interpretation

Flexible

Expand lab operations and workflow with multiple tests and configurations.

Removable strips allow multiple configurations

Test both drug levels and anti-drug antibody levels

Manual or automated mode

High Quality

Rely on results with a high quality product.

High specificity and sensitivity

Supported by a large number of peer-reviewed articles